Radical innovation in vaccine development
Supported by EUREKA Eurostars, DRIVE is a consortium consisting of four EU partners, funded by their national subsidy point. DRIVE makes use of virus-like particles (VLP) evolution to develop vaccine candidates against dengue virus. Their immunogenicity, safety, and efficacy will be assessed by Artemis using state-of-the-art assays to measure several arms of the immune response.
